Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexsero + Routine Vaccines in Healthy Infants in Taiwan
NCT02173704Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant neisseria meningitidis group B nhba fusion protein in meningococcal disease, sponsored by GSK. Started Sep 2014; status: completed.
02
Drugs
recombinant neisseria meningitidis group B nhba fusion protein
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT02173704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02173704.